Redwood City, CA, United States of America

Sandra M Zurawski

USPTO Granted Patents = 38 

 

 

Average Co-Inventor Count = 4.2

ph-index = 10

Forward Citations = 341(Granted Patents)


Location History:

  • Redwood City, CA (US) (1991 - 1997)
  • San Juan Bautista, CA (US) (2002 - 2011)
  • Midlothian, TX (US) (2011 - 2024)

Company Filing History:


Years Active: 1991-2025

Loading Chart...
Loading Chart...
Loading Chart...
38 patents (USPTO):Explore Patents

Title: Innovations in HPV Vaccination: The Contributions of Sandra M. Zurawski

Introduction

Sandra M. Zurawski, based in Redwood City, CA, is a leading inventor in the field of biotechnology and vaccines. With an impressive portfolio of 38 patents, Zurawski has made significant strides in developing innovative vaccines targeting human papillomavirus (HPV) and its related diseases.

Latest Patents

Zurawski's latest patents focus on vaccines against HPV and HPV-related diseases. These novel vaccines incorporate anti-human dendritic cell surface receptor antibodies, particularly CD40, along with E6/7 proteins from HPV types 16 and 18. Notably, the technology extends beyond these two strains and can create vaccines for E6/7 proteins from any HPV type. The designed HPV vaccines are engineered to effectively target dendritic cells and other antigen presenting cells, aiming to induce strong immune responses from both CD4+ and CD8+ T cells. The applications of these vaccines are dual-faceted, serving both as a preventive measure against HPV infection and as a treatment for HPV-related diseases, including various cancers.

Career Highlights

Sandra Zurawski has worked with prominent organizations, including the Baylor Research Institute and Schering Corporation. Her career reflects a commitment to advancing medical research and developing innovative solutions to combat infectious diseases.

Collaborations

Collaboration has been a crucial element in Zurawski's career. She has worked alongside notable researchers such as Gerard Zurawski and SangKon Oh, furthering advancements in the field of vaccine development through shared expertise and innovation.

Conclusion

Sandra M. Zurawski's contributions to vaccine technology, particularly in relation to HPV, exemplify the important intersection of scientific research and practical application. With her extensive portfolio and collaborative efforts, Zurawski remains a pivotal figure in the ongoing fight against HPV-related diseases, paving the way for future innovations in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…